Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Whitehall Laboratories was a major American consumer healthcare company that operated as a division of American Home Products, which later became Wyeth. The company was a leader in the over-the-counter (OTC) drug market, responsible for the commercialization of household brands such as Advil, Anacin, and Preparation H. In the 1990s, it merged with A.H. Robins to form Whitehall-Robins Healthcare, further expanding its portfolio to include products like Robitussin and ChapStick. Following Pfizer's acquisition of Wyeth in 2009, the Whitehall legacy brands were integrated into Pfizer's consumer health division. Many of these brands are now part of Haleon, the consumer healthcare spin-off from GSK and Pfizer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Whitehall Laboratories.